Monthly number and proportion of infections and incidence rates among the medical laboratory services staff by sex, 1 April 2020–31 March 2021. by Kerry Sidwell Wilson (12890013)

Subjects:

Infection rate of COVID-19 reported in OHASIS for medical laboratory staff, by occupation group over 12 months. by Kerry Sidwell Wilson (12890013)

Subjects:

COVID-19 cases in Uzbekistan since February 2020 to July 2023 (according to Worldometer, https://www.worldometers.info). by Gulnoza Esonova (20291200)

Correlations between original epidemic risk estimates for March 16, 2020 (assuming uniform <i>R</i>_<i>e</i>) and case count increases in the subsequent week across all counties. by Emily M. Javan (15194865)

Subjects:

Time dependence of the scaling exponents for COVID-19 cases and deaths. by Haroldo V. Ribeiro (9411459)

“…<p>(A) Dependence of the exponent <i>β</i>_<i>c</i> on the number of days after the first two daily cases of COVID-19 (<i>t</i>_<i>c</i>). …”

Sensitivity analyses: Relative Incidences estimated by Self-Controlled Case Series model by vaccine brand and dose: 287 Guillain Barré Syndrome events in the anti-COVID-19 vaccinat... by Cristina Morciano (9397154)

Subjects:

Detecting dispersion changes in case count time series. by Rachael Aber (21703264)

Subjects:

Risk factors for mucormycosis among never-hospitalised COVID-19 patients, multi-centric case-control study of post-COVID rhino-orbito-cerebral mucormycosis, India, 2021. by Manickam Ponnaiah (294619)

Subjects:

Risk factors for mucormycosis among ever-hospitalised COVID-19 patients, multi-centric case-control study of post-COVID rhino-orbito-cerebral mucormycosis, India, 2021. by Manickam Ponnaiah (294619)

Subjects:

Patient characteristics comparing the spring and autumn period, ECMO = extracorporeal membrane oxygenation. by Christian Karagiannidis (64152)

Subjects:

Patient characteristics by type of ventilation. by Christian Karagiannidis (64152)

Subjects:

Time distribution of NIV failure (NIV-F) by day, comparing spring and autumn period. by Christian Karagiannidis (64152)

Subjects:

S1 File - by Young Jae Kim (8098697)

Subjects:

Summary statistics of main outcomes by case. by Anita Svadzian (15927140)

Subjects:

Quarterly all-forms TB case notifications and case notification rates from Q1 2016 to Q4 2020, for the intervention area (6 regions) and control area (4 regions). by Zourriyah Adamou Mana (13119048)

Subjects:

Table_1_Impact of Covid-19 on Household Food Waste: The Case of Italy.DOCX by Gioacchino Pappalardo (9717413)

Comparison of estimated epidemic risks and reported increases in cases at the county level between March 16 and March 23, 2020. by Emily M. Javan (15194865)

Subjects:

Base-case analysis. by Akiko Kowada (14659965)

“…For 10,517,942 individuals born between 2011 and 2021, HTLV-1 antenatal screening costs US$785 million, increases19,586 QALYs and 631 LYs, and prevents 125,421 HTLV-1 carriers, 4,405 ATL cases, 3,035 ATL-associated deaths, 67 HAM/TSP cases, and 60 HAM/TSP-associated deaths, compared with no screening over a lifetime.…”

Global distribution of <i>Plasmodium</i> spp. infection among patients with COVID-19 (blue color). by Polrat Wilairatana (50854)

Subjects:

Trends in COVID-19 deaths in Oregon, for both the overall population and by agricultural worker type, between March 1, 2020 and February 27, 2021. by Raul Cruz-Cano (3751321)

Subjects: